Meridian BioGroup acquired by Pace® Life Sciences

Expanding Regulatory, Compliance, and Validation Capabilities to the Biotechnology and Pharmaceutical Markets

Meridian BioGroup

We are excited to announce, that Meridian BioGroup has been acquired by Pace® Life Sciences. The acquisition allows Pace® to provide regulatory and quality consulting services to support clients throughout the drug development process and improve commercial compliance in FDA-regulated environments.

President of Pace® Life Sciences Greg Kupp said, “The addition of the Meridian BioGroup team brings new dimensions to the range of services we provide to our clients. From early regulatory strategy discussions to master planning and validation as programs scale for commercialization, we will be able to help clients at every stage of their journey on through to continued compliance, training, and auditing.”

We’re looking forward to the future and working together!

read the full release at:


4539 Metropolitan Ct., Frederick MD 21704